For CURA Diagnostics’ Point-of-Care Devices front, the electrochemical sensor at the heart of our technology platform integrates all the necessary building blocks for successful enzymatic, protein, and small molecule detection into the functional chemistry itself. This method precludes the need for potentially hazardous additives, strict lab conditions, trained technicians, and long test durations that are commonplace for other protein/small molecule electrochemical sensors and other point of care (POC) and over the counter (OTC) diagnostic technologies. At the same time our proprietary one-step deposition process allows for inexpensive and simple manufacturing, sensor shelf lives of greater than 1 year, and minimized batch-batch variation. Our sensors have demonstrated measurement of salivary glucose and SARS-CoV-2 with excellent clinical accuracy, proving the 100x lower limit of quantification over traditional blood glucose systems and its ability to compete with prominent rapid immunoassays at lower turn-around times. Moreover, the construction of the platform chemistry lends itself to detection of a variety of different analytes with simple modification.